In each of the following cancers, only one KLK was significantly upregulated: hepatocellular carcinoma (KLK4: 2-fold), stomach adenocarcinoma (KLK6: 11-fold) and esophageal carcinoma (KLK4: 3-fold). Here, KLK6 is linked to hepatocellular carcinoma.